Description
This compound is a taxol derivative that may exhibit antiviral and anticancer chemotherapeutic activities.
7-(Triethylsilyl)-10-deacetylbaccatin III
Product ID T0091
Cas No. 115437-18-8
Purity ≥97%
| Product Unit Size | Cost | Quantity | Stock |
|---|
Product Info
| Cas No. | 115437-18-8 |
|---|---|
| Purity | ≥97% |
| Formula | C35H50O10Si |
| Formula Wt. | 658.85 |
| IUPAC Name | [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1,12,15-trihydroxy-10,14,17,17-tetramethyl-11-oxo-9-triethylsilyloxy-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate |
| Appearance | White Powder |
Shipping and Storage
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
Downloads
| MSDS | |
|---|---|
| Info Sheet |
References
Krawczyk E, Luczak M, Kniotek M, et al. Cytotoxic, antiviral (in-vitro and in-vivo), immunomodulatory activity and influence on mitotic divisions of three taxol derivatives: 10-deacetyl-baccatin III, methyl (N-benzoyl-(2'R,3'S)-3'-phenylisoserinate) and N-benzoyl-(2'R,3'S)-3'-phenylisoserine. J Pharm Pharmacol. 2005 Jun;57(6):791-7. PMID: 15969936.
Samaranayake G, Neidigh KA, Kingston DG. Modified taxols, 8. Deacylation and reacylation of baccatin III. J Nat Prod. 1993 Jun;56(6):884-98. PMID: 8102392.